Swiss pharmaceuticals group Novartis tapped industry veteran and banking high-flier Jonathan Symonds to succeed Raymund Breu as chief financial officer, in a move welcomed by the market. Symonds, who spent eight years as CFO of UK-based rival Astrazeneca, will join Novartis on Sept. 1 from Goldman Sachs, where he is managing director of investment banking.
Building on the April 2025 announcement, Dow will take actions across its three operating segments to support European profitability, resulting in the closure of sites in Germany and the UK.
Novo Nordisk announced a global workforce reduction of approximately 9,000 positions to streamline operations and reinvest DKK 8 billion (€1 billion) in growth opportunities for diabetes and obesity treatments.
Compelling solutions through strategic partnerships
Ineos CEO Ineos calls on European politicians to save the chemical industry.
BASF sells a majority stake in its coatings business to the investor Carlyle.
